ARTICLE
Auteur(s) :, Yohei Kitamura, Madoka Sato*, Atsushi
Hatamochi, Soji Yamazaki
Department of Dermatology, Dokkyo University School of Medicine,
Mibu, Tochigi 321-0293, Japan Fax : (+81) 282 86 3470.
accepté le 20 Juin 2004
Necrolytic migratory erythema (NME) is the cutaneous manifestation
which occurs in patients with glucagonoma syndrome, i.e.,
glucagon-secreting α-islet cell tumor of the pancreas [1]. Less
often, NME occurs in patients without glucagonoma. Among them,
liver diseases are the most common associated conditions [2].
Recently, necrolytic acral erythema has been described as a
distinct entity characterized by its acral distribution and
association with hepatitis C virus [3]. We report a case of NME
associated with hepatitis B.
Case report
A 53-year-old Japanese man was admitted to our department in August
2003 with a 2-month history of pruritic skin lesions. This
dermatitis was rapidly exacerbated by his scratching several days
before admission. On physical examination, the patient was a thin
man with a body mass index of 18.6. He mentioned that he lived
alone and had a diet composed primarily of alcohol and meat. He was
noted to have a dusky, scaling, erosive dermatitis involving his
fingers and soles (( figure 1 )A). A large
well-demarcated crusted plaque was noted on his left lower limb ((
figure 1 )B).
Several psoriasiform eruptions with peripheral scaling were present
on his legs.
Laboratory studies revealed elevated serum aspartate
aminotransferase (81 U/l [normal, 10 to 37]), alanine
aminotransferase (45 U/l [normal 3 to 34]), γ-glutamyl
transpeptidase (101 U/l [normal, 18 to 66]), total bilirubin (1.8
mg/dl, [normal, 0.1 to 1.0]) and decreased serum levels of albumin
(3.1 mg/dl [normal, 4.0 to 5.2]), total cholesterol (117 mg/dl
[normal, 120 to 260]), and zinc (45 μg/dl [normal, 61 to 121]).
Platelet count was 73 × 109/l (normal, 163 to 428). He
had a hyperchromic macrocytic anemia with decreased level of folic
acid (1.2 ng/ml [normal, 3.6 to 12.9]). Serum glucagon level was
normal.
Evaluation of his hepatitis serological status confirmed that he
was positive for hepatitis B surface antigen, hepatitis B e antigen
and antibody. Hepatitis B core antibody was highly positive.
Antihepatitis C antibodies were not detected. He was considered a
chronic asymptomatic hepatitis B carrier.
An abdominal computed tomographic scan failed to reveal either a
pancreatic neoplasm or a hepatic mass.
A biopsy specimen taken from a crusted plaque on his left lower
limb showed hyperkeratosis, parakeratosis and focal necrotic
keratinocytes in the upper stratum spinosum and inflammatory
infiltrates into the epidermis. Moderate superficial perivascular
infiltrates of lymphocytes are present in the papillary dermis ((
figure 2 )A).
Psoriasiform erythema on the thigh revealed areas of epidermal
necrosis, in which the upper layers of the epidermis showed abrupt
necrosis, and pallor keratinocytes, some of which showed
balloon-like cytoplasm (( figure 2 )B).
After hospitalization, his dermatitis promptly resolved with
emollients and the levels of liver function tests, platelet count
and serum zinc concentration were normalized.
Discussion
Wilkinson [4] introduced the term “necrolytic migratory erythema”
to describe the rash which was associated with pancreatic
glucagon-secreting α-islet cell tumors. The lesions are
characterized by erythematous scaling, exudative, or eroded
dermatitis which involves the central part of the face, perineum,
and distal extremities. The rash is related to trauma in some areas
[5].
NME belongs to the family of necrolytic erythemas that include
acrodermatitis enteropathica, pellagra, essential fatty acid
deficiencies, and recently described necrolytic acral erythema [3].
These entities share similar clinical and histologic findings.
Acrodermatitis enteropathica is related to zinc deficiency. The
autosomal recessive inherited form of acrodermatitis enteropathica
is suggested to be caused by a mutation in the gene encoding an
intestinal zinc transporter of the ZIP family, SLC39A4 [6].
Acquired zinc deficiency dermatosis presents at any age due to a
variety of underlying disorders including dietary factors (anorexia
nervosa, alcoholism, parenteral nutrition without zinc
supplementation), gastrointestinal diseases and liver diseases
[6–9]. Patients with NME are reported to have zinc deficiency [2,
5]. Our case also had zinc deficiency. Our patient had a dietary
problem in addition to the hepatitic dysfunction, and both of them
might lead to a negative zinc balance. There is no definition to
differentiate acquired acrodermatitis enteropathica from
non-glucagonoma- associated NME. These entities may be similar in
etiology. We used the term “necrolytic migratory erythema” in the
title because the term “acquired acrodermatitis enteropathica”
gives the impression that zinc deficiency is the primary event of
the dermatitis, contrary to the fact that several factors have been
discussed in relation to the etiology of this dermatitis [5].
Necrolytic acral erythema is characterized by its exclusive
acral distribution of lesions and association with hepatitis C
infection [4]. This term is too restrictive as an entity and
necrolytic acral erythema may belong to the spectrum of NME. NME
without glucagonoma is commonly associated with impaired hepatic
function, however, association of viral infection has never been
discussed except the cases reported as necrolytic acral erythema.
Our patient represents the first case of NME with hepatitis B
infection. Hepatitis viruses may be causative factors of NME.
The pathogenesis of NME is still unknown. Although zinc
deficiency may contribute to the etiology, many patients are
reported to have a normal zinc concentration [5]. Kasper et al.
[10] speculate that an abnormality in hepatic metabolism is
responsible for the dermatitis. The case presented herein further
supports this speculation. We should increase the awareness of the
relationship between skin disease and liver disease.
References
1 Johnson SM, Smoller BR, Lamps LM, Horn TD.
Necrolytic migratory erythema as the only presenting sign of a
glucagonoma. J Am Acad Dermatol 2003; 49: 325-8.
2 Marinkovich MP, Botella R, Datloff J,
Sangueza OP. Necrolytic migratory erythema without glucagonoma
in patients with liver disease. J Am Acad Dermatol 1995; 32:
604-9.
3 Khanna VJ, Shieh S, Benjamin J, Somach S,
Zaim MT, Dorner Jr. W, Shill M, Wood GS.
Necrolytic acral erythema associated with hepatitis C. Arch
Dermatol 2000; 136: 755-7.
4 Wilkinson DS. Migrant necrotic erythema revealing a
cancer of the pancreas. Ann Dermatol Syphiligr (Paris) 1973; 100:
382-3.
5 Mullans EA, Cohen PR. Iatrogenic necrolytic
migratory erythema: a case report and review of
nonglucagonoma-associated necrolytic migratory erythema. J Am Acad
Dermatol 1998; 38: 866-73.
6 Quirk CM, Seykora J, Wingate BJ,
Cotsarelis G. Acrodermatitis enteropathica associated with
anorexia nervosa. JAMA 2002; 288: 2655-6.
7 Weismann K, Wadskov S, Mikkelsen HI,
Knudsen L, Christensen KC, Storgaard L. Acquired
zinc deficiency dermatosis in man. Arch Dermatol 1978; 114:
1509-11.
8 Krasovec M, Frenk E. Acrodermatitis enteropathica
secondary to Crohn’s disease. Dermatology 1996; 193: 361-3.
9 Reichel M, Mauro TM, Ziboh VA, Huntley AC,
Fletcher MP. Acrodermatitis enteropathica in a patient with
the acquired immunodeficiency syndrome. Arch Dermatol 1992; 128:
415-7.
10 Kasper CS, McMurry K. Necrolytic migratory erythema
without glucagonoma versus canine superficial necrolytic
dermatitis: is hepatic impairment a clue to pathogenesis? J Am Acad
Dermatol 1991; 23: 534-41.
|